UPMC Hillman Cancer Center

Research Funding Opportunities

Research Funding Opportunities

Show newest first

View funding announcements by clicking on the title. Click on the headings "Title", "Category" or "Deadline" to sort listings. Click here for FAQ about this webpage.

Title Category Deadline
Bioengineering Research Partnerships (U01 Clinical Trial Optional) ALL 05/08/18
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2018, 2019, and 2020 (P50 Clinical Trial Required) ALL 05/25/18
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) ALL 05/25/18
Cancer Research Education Grants Program - Courses for Skills Development (R25) ALL 05/25/18
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) ALL 05/25/18
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) ALL 05/25/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) ALL 05/29/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) ALL 05/29/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) ALL 05/29/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) ALL 05/29/18
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) ALL 05/29/18
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) ALL 05/29/18
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) ALL 05/29/18
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) ALL 05/29/18
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) ALL 05/29/18
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) ALL 05/30/18
Serious Adverse Drug Reaction Research (R21) ALL 06/01/18
Serious Adverse Drug Reaction Research (R01) ALL 06/01/18
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) ALL 06/05/18
The Role of Mobile Genetic Elements in Cancer (R01) ALL 06/05/18
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01) ALL 06/05/18
Metabolic Reprogramming to Improve Immunotherapy (R01) ALL 06/05/18
Examination of Survivorship Care Planning Efficacy and Impact (R01) ALL 06/05/18
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) ALL 06/05/18
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) ALL 06/05/18

Next 25 rows